
Topic
Interventional Radiology (IR)
337 Podcasts • 84 Cases • 20 Courses on BackTable
Hear how experienced clinicians in Interventional Radiology (IR) approach day-to-day decision-making on BackTable. Learn from podcasts, cases, and courses curated by physician content creators. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.

Episode # 657 • 23 Jun 2026
Advanced Techniques in Y90 Cancer Treatment
What do you do when Y-90 doesn’t deliver the results you expected? In this episode of the 2026 HCC Creator Weekend™, host Dr. Tyler Sandow is joined by Drs. Beau Toskich and Juan Gimenez to discuss the technical challenges and troubleshooting strategies that can make or break a Y-90 radioembolization case. Together, they explore innovative approaches like the PREDATr technique, share tips for reducing complications, and offer guidance on optimizing outcomes for patients with complex liver tumors.
This podcast is supported by an educational grant from Sirtex and Boston Scientific.
More on Interventional Radiology (IR)
Loading recent podcasts…
Vascular & IR # 657
Jun 23, 2026
with Dr. Beau Toskich, Dr. Juan Gimenez, Dr. Tyler Sandow
What do you do when Y-90 doesn’t deliver the results you expected? In this episode of the 2026 HCC Creator Weekend™,...
Vascular & IR # 655
Jun 16, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone, Dr. Zach Berman
How is Y90 radioembolization rewriting the rules for managing large HCC tumors and creating new curative-intent...
Vascular & IR # 654
Jun 12, 2026
with Dr. Jay Giri, Dr. Trevor Cummings, Dr. Michael Barraza
Will new guidelines redefine risk and therapy in pulmonary embolism care? In this episode of the BackTable Podcast,...
640+ listens
Vascular & IR # 653
Jun 9, 2026
with Dr. Beau Toskich, Dr. Christopher Malone, Dr. Venkatesh Krishnasamy
How can targeted liver radiation unlock surgical or transplant options for tough hepatocellular carcinoma (HCC) cases?...
920+ listens
Vascular & IR # 656
Jun 19, 2026
with Dr. Neil Resnick, Dr. Francis Kang, Dr. Christopher Beck
Are new technologies and teamwork the key to better fibroid treatment? In this episode of the BackTable Podcast, Drs....
Tumor Board # 66
Jun 16, 2026
with Dr. Gregory Botta, Dr. Zach Berman, Dr. Rebekah White
How do seasoned clinicians navigate the complex web of complications that accompany pancreatic cancer? In this episode...
Cardiology # 38
Jun 12, 2026
with Dr. Jay Giri, Dr. Trevor Cummings, Dr. Michael Barraza
Will new guidelines redefine risk and therapy in pulmonary embolism care? In this episode of the BackTable Podcast,...
50+ listens
Vascular & IR # 652
Jun 5, 2026
with Dr. Gian Paolo Zamboni, Dr. Neil Jain
When hemodialysis-dependent patients exhaust all conventional venous access options, how do IRs navigate complex...
1,300+ listens
VI Case
Mar 20, 2026
with Dr. Kevin Wong and Dr. Aparna Baheti
VI Case
Jul 8, 2025
with Dr. Tyler Sandow, Dr. Zach Berman and Dr. Venkatesh Krishnasamy
VI Case
Jul 8, 2025
with Dr. Tyler Sandow, Dr. Zach Berman and Dr. Venkatesh Krishnasamy
VI Case
Jul 22, 2025
with Dr. Tyler Sandow, Dr. Zach Berman and Dr. Venkatesh Krishnasamy
VI Case
Jul 1, 2025
with Dr. Nima Kokabi, Dr. Tyler Sandow and Dr. Venkatesh Krishnasamy
VI Case
Jul 8, 2025
with Dr. Tyler Sandow, Dr. Zach Berman and Dr. Venkatesh Krishnasamy
VI Case
Jul 22, 2025
with Dr. Tyler Sandow, Dr. Zach Berman and Dr. Venkatesh Krishnasamy
VI Case
Jul 22, 2025
with Dr. Tyler Sandow, Dr. Zach Berman and Dr. Venkatesh Krishnasamy
VI Course
2.5 hours, 28 lessons
Tumor Board Course
2 CME/CE credits, 2.5 hours, 19 lessons
Tumor Board Course
2 CME/CE credits, 2.5 hours, 26 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.





